Thousands of individuals are pursuing legal action against Johnson & Johnson, alleging that their talcum powder usage led to the development of cancer.
In the UK, around 3,000 people are suing the pharmaceutical company, claiming that Johnson’s Baby Powder was knowingly sold contaminated with asbestos. The plaintiffs assert that either they or their family members contracted ovarian cancer or mesothelioma due to talc use and are now seeking compensation at the High Court in London.
Among those involved in the lawsuit is Janet Fuschillo, who disclosed using J&J’s baby powder since the 1960s and receiving an ovarian cancer diagnosis seven years ago. Janet, aged 75, expressed dismay over using talc on herself and her children for nearly five decades, emphasizing her distress at potentially harming her children.
Legal representatives for the group alleged in court filings that Johnson & Johnson concealed the risks associated with talc for many years, switching to corn starch in the UK’s baby powder production only in 2023. KP Law is handling the case against the company, a major talc distributor.
Responding to the claims, a spokesperson for Kenvue, formerly part of J&J, defended the purity and safety of the talc used in baby powder, stating compliance with regulations and the absence of asbestos or cancer-causing properties. Talc, a natural mineral mined from the earth, was emphasized as a standard ingredient.
Michael Rawlinson KC, representing the claimants, highlighted the presence of asbestos in talc deposits supplied to Johnson & Johnson, accusing the company of downplaying health risks and actively concealing contamination information. He contended that the company prioritized profit and reputation over consumer safety.
Mesothelioma, primarily caused by asbestos exposure, typically affects the lungs through inhalation of microscopic fibres, as noted by the NHS. Patricia Angell shared her husband Edward’s tragic mesothelioma diagnosis and subsequent death, attributing his exposure to contaminated talc as a contributing factor despite his unawareness of asbestos contact.
Refuting the allegations, a Kenvue spokesperson reiterated the safety credentials of Johnson’s Baby Powder, citing extensive testing by reputable labs and health authorities globally. The company maintained that their talc adhered to regulatory standards, was asbestos-free, and did not pose cancer risks.
Johnson & Johnson’s stance on the matter was redirected to Kenvue, emphasizing the separation of the consumer health business and the transfer of talc-related liabilities post-August 2023. The company affirmed its commitment to addressing inquiries through Kenvue, reiterating the compliance and safety standards of their products.
